Our approach provides the flexibility of access to all species used in regulatory toxicology using numerous routes of administration, while our state-of-the-art, AAALAC-accredited facilities ensure that we deliver an outstanding level of service.
Significant increase in overall capacity
MDS Pharma Services has recently completed an expansion of our drug safety assessment facility. In addition to significantly increasing our overall capacity, the facility expansion featured new histopathology laboratories, and refurbishment of our existing histopathology and immunohistochemistry laboratories.
For more information on study design, pricing, contract and turnaround contact your MDS Pharma Services representative.
